TY - JOUR
T1 - Trisomy 10 in a child with acute nonlymphocytic leukemia followed by relapse with a different clone
AU - Sakai, Yasunari
AU - Nakayama, Hideki
AU - Matsuzaki, Akinobu
AU - Nagatoshi, Yoshihisa
AU - Suminoe, Aiko
AU - Honda, Keiko
AU - Inamitsu, Takeshi
AU - Ohga, Shouichi
AU - Hara, Toshiro
PY - 1999/11
Y1 - 1999/11
N2 - We report a 2-year-old Japanese boy with acute nonlymphocytic leukemia (ANLL) having trisomy 10 as the sole chromosomal abnormality. The majority of the marrow blasts had lobulated nuclei and Auer rods in their cytoplasm. The blasts were positive for peroxidase, CD13, CD15, and CD33, but negative for esterase, CD3, CD7, CD34, and HLA-DR, indicating a diagnosis of ANLL, atypical M2 in French-American-British (FAB) classification. He was treated with combination chemotherapy, including anthracyclines, etoposide, and cytosine arabinoside. Four months after achieving the first remission, the disease relapsed during the consolidation therapy, and he died 9 months later. Trisomy 10 was not detected at relapse, and blasts showed phenotypes different from those at initial diagnosis. The present case suggests that the prognosis of acute leukemia with trisomy 10 in the pediatric age group may not be good, and that further studies are required to clarify the association of trisomy 10 with leukemogenesis and disease progression. Copyright (C) 1999 Elsevier Science Inc.
AB - We report a 2-year-old Japanese boy with acute nonlymphocytic leukemia (ANLL) having trisomy 10 as the sole chromosomal abnormality. The majority of the marrow blasts had lobulated nuclei and Auer rods in their cytoplasm. The blasts were positive for peroxidase, CD13, CD15, and CD33, but negative for esterase, CD3, CD7, CD34, and HLA-DR, indicating a diagnosis of ANLL, atypical M2 in French-American-British (FAB) classification. He was treated with combination chemotherapy, including anthracyclines, etoposide, and cytosine arabinoside. Four months after achieving the first remission, the disease relapsed during the consolidation therapy, and he died 9 months later. Trisomy 10 was not detected at relapse, and blasts showed phenotypes different from those at initial diagnosis. The present case suggests that the prognosis of acute leukemia with trisomy 10 in the pediatric age group may not be good, and that further studies are required to clarify the association of trisomy 10 with leukemogenesis and disease progression. Copyright (C) 1999 Elsevier Science Inc.
UR - http://www.scopus.com/inward/record.url?scp=0033230687&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033230687&partnerID=8YFLogxK
U2 - 10.1016/S0165-4608(99)00087-4
DO - 10.1016/S0165-4608(99)00087-4
M3 - Article
C2 - 10565299
AN - SCOPUS:0033230687
SN - 0165-4608
VL - 115
SP - 47
EP - 51
JO - Cancer Genetics and Cytogenetics
JF - Cancer Genetics and Cytogenetics
IS - 1
ER -